Quick Answer
CERO THERAPEUTICS HOLDINGS, INC. reported Total Assets of $6.21 million for the year ending 2024.
- CERO THERAPEUTICS HOLDINGS, INC. showed an increase of +21.1% in Total Assets from 2023 to 2024.
- This data is from CERO THERAPEUTICS HOLDINGS, INC.'s annual report (Form 10-K), filed with the SEC on April 15, 2025.
- XBRL data for this metric is available from 2021 to 2024 (4 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Quarterly values from 10-Q filings: Q3 2021: $301.0 thousand | Q1 2022: $179.78 million | Q2 2022: $179.72 million | Q3 2022: $180.45 million | Q1 2023: $14.43 million | Q2 2023: $14.11 million | Q3 2023: $8.47 million | Q1 2024: $9.05 million | Q2 2024: $7.37 million | Q4 2024: $6.21 million | Q1 2025: $7.99 million | Q2 2025: $6.20 million | Q3 2025: $3.91 million.
- Over the full 4 years of available data (2021 to 2024), CERO THERAPEUTICS HOLDINGS, INC.'s Total Assets has declined by 96.6%.
- Historical annual values: Fiscal year 2024: $6.21 million | Fiscal year 2023: $5.13 million | Fiscal year 2022: $42.37 million | Fiscal year 2021: $180.08 million.
- Data sourced from SEC EDGAR public filings as of August 5, 2026.
Last verified: